Aging is associated with increased susceptibility to pulmonary infections with worse prognosis. My lab is focused on understanding how host-pathogen interactions change with aging and on elucidating the factors that govern disease outcome following infection. We are also focused on age driven changes in vaccine responses, understanding how defects in innate immunity (neutrophils) impair antibody responses to vaccines in aged hosts, and designing improved vaccines for use in aged hosts. We are studying these aspects in the context of S. pneumoniae, which remain the leading cause of community-acquired pneumonia in older adults (>65 years old) despite the availability of vaccines. Projects in my lab include 1) the role of damage responses in host outcome focusing on the extracellular adenosine pathway and how it changes with aging, 2) the role of neutrophils in disease outcome and how their responses get disrupted with age, 3) protective memory responses to pneumococcal vaccines in young and aged hosts, 4) how host sex and genetic background influence age-driven changes in neutrophil responses, infection and vaccine outcomes and lastly 5) how the above responses change in the context of polymicrobial infections focused on secondary bacterial pneumonia following influenza A virus co-infection.